Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histamine release refers to the process by which the biogenic amine histamine is liberated from storage sites within cells, primarily mast cells and basophils, into surrounding tissues or circulation. This event is a central component of immune responses, particularly in allergic reactions and inflammation. Excessive or inappropriate histamine release underlies many allergic conditions and may contribute to autoimmune diseases and persistent inflammatory states.
N/A (process itself, not a drug target). Drugs can inhibit specific receptors (H1, H2, etc.) or stabilize mast cells to prevent degranulation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histamine Release (N/A).